STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8
Clinical trials for STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could Fine-Tune radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test (NavDx) can help doctors decide the right amount of radiation for people with HPV-related throat cancer. The goal is to give enough treatment to control the cancer while reducing side effects. About 455 adults with certain stages of throat ca…
Matched conditions: STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug aims to prevent painful mouth sores in head and neck cancer treatment
Symptom relief Recruiting nowThis phase 2 trial tests whether adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 participants will receive either BMX-001 or a placebo alongside usual mouth rinses and pain medication. The goal is t…
Matched conditions: STAGE I OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 15, 2026 10:44 UTC